UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - theodoros+kelesidis
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Nrf2 Agonist as Therapeutic Modality to Increase Antiviral Efficacy of Existing Antivirals Against Coronavirus Infections (UCLA Case No. 2022-325)
UCLA researchers in the School of Medicine’s department of Infectious Disease have identified a novel therapeutic approach that can supplement existing FDA approved treatments for SARS-CoV2-2 infections to provide robust treatments against morbidity. BACKGROUND: The World Health Organization reports that as of June 2023, there have been over...
Published: 2/23/2024
|
Inventor(s):
Theodoros Kelesidis
Keywords(s):
Coronavirus
,
COVID-19
,
Paxlovid
,
SARS-CoV-2
,
Viral Medication
Category(s):
Therapeutics > Infectious Diseases
2021-272: APOA-I Mimetic Peptides as Antiviral Therapeutic Strategy
SUMMARY: Researchers from UCLA’s Department of Medicine have developed an oral antiviral using the apoA-I mimetic peptide 4F alone or in combination with statins to prevent and treat infection of SARS-CoV-2, including long-term post-infection symptoms. ApoA-I mimetic peptides can also be given systemically as injection to attenuate viral replication...
Published: 9/5/2023
|
Inventor(s):
Theodoros Kelesidis
Keywords(s):
Category(s):
Therapeutics
,
Therapeutics > Infectious Diseases
,
Therapeutics > Infectious Diseases > COVID
2014-425 A HIGH THROUGHPUT BIOCHEMICAL FLUOROMETRIC METHOD FOR MEASURING HDL REDOX ACTIVITY
SummaryUCLA researchers in the Department of Medicine have developed a method of screening for the functional properties of high-density lipoprotein (HDL) in the blood that may serve as a more accurate risk indicator of cardiovascular disease.BackgroundCardiovascular disease remains the number one cause of death for both men and women in the United...
Published: 7/19/2023
|
Inventor(s):
Theodoros Kelesidis
,
Srinivasa Reddy
,
Otto Yang
Keywords(s):
Cardiovascular
,
Diagnostic Markers & Platforms
,
Life Science Research Tools
,
Targets And Assays
Category(s):
Life Science Research Tools
,
Diagnostic Markers
,
Diagnostic Markers > Targets And Assays
,
Therapeutics > Cardiovascular